Cervical Preparation With Mifepristone Prior to Osmotic Dilators
Status:
Terminated
Trial end date:
2021-02-26
Target enrollment:
Participant gender:
Summary
The investigators plan to study the role of mifepristone prior to the placement of cervical
osmotic dilators to evaluate if the medication helps increase the number of dilators. This
may help improve safety of dilation and evacuation (D&E) procedures.